Parnate Pharmacology, Pharmacokinetics, Studies, Metabolism - Tranylcypromine

Parnate Pharmacology, Pharmacokinetics, Studies, Metabolism - Tranylcypromine

CLINICAL PHARMACOLOGY

Tranylcypromine is a non-hydrazine monoamine oxidase inhibitor with a rapid onset of activity. It increases the concentration of epinephrine, norepinephrine, and serotonin in storage sites throughout the nervous system and, in theory, this increased concentration of monoamines in the brain stem is the basis for its antidepressant activity. When tranylcypromine is withdrawn, monoamine oxidase activity is recovered in 3 to 5 days, although the drug is excreted in 24 hours.